>> Login
>> New User Registration
September 9, 2010

Symposium Chair


Steven T. Rosen, MD, FACP
Director, Robert H. Lurie Cancer Center
Northwestern University
Chicago, IL

Expert Faculty

Second Annual Symposium on Personalized Therapies and Best Clinical Practices for Hematologic Malignancies coming soon.

Taught by the top academic experts in hematology this is THE symposium on hematology that you should attend in 2011. It contains the most up-to-date data from the recent ASH meeting. This symposium will help clinicians improve their selection of the most appropriate therapeutics, and will also help clinicians to identify the patient sub-populations of hematology who will respond to specific drug therapies.

Agenda and faculty below. Remainder of the information will be available October 2010.


Expert Faculty Back to Top


Jessica K. Altman, MD
Division of Hematology/Oncology
Northwestern University
Robert H. Lurie Comprehensive Cancer Center
Chicago, IL



 


S. Vincent Rajkumar, MD
Professor of Medicine
Division of Hematology
Department of Medicine
Mayo Clinic
Rochester, MN




Bruce D. Cheson, MD
Professor of Medicine
Hematology/Oncology
Head of Hematology
Director, Hematology Research
Lombardi Comprehensive Cancer Center
Georgetown University Hospital
Washington, DC



 


Steven T. Rosen, MD, FACP
Director, Robert H. Lurie Cancer Center
Northwestern University
Chicago, IL




Michael Deininger, MD, PhD
Professor of Medicine
Division of Hematology & Medical Oncology
Section Head, Center for Hematologic Malignancies
Oregon Health & Science University
Portland, OR



 


Tait D. Shanafelt, MD
Associate Professor of Medicine
Division of Hematology
Department of Medicine
Mayo Clinic
Rochester, MN




Madeleine Duvic, MD
Deputy Department Chair
Department of Dermatology
Professor of Medicine and Dermatology
Division of Internal Medicine
The University of Texas MD Anderson Cancer Center
Houston, TX

 


Moshe Talpaz, MD
Professor, Department of Internal Medicine
Alexander J. Trotman Professor of Leukemia Research
Associate Director of Translational Research
Associate Chief/Director of Hematologic Malignancies
University of Michigan Comprehensive Cancer Center
Ann Arbor, MI




Andrew Evens, MD
Division of Hematology/Oncology
Northwestern University
Robert H. Lurie Comprehensive Cancer Center
Chicago, IL



 


Julie M. Vose, MD
Neumann M. and Mildred E. Harris Professor
Chief, Section of Hematology/Oncology
Professor of Medicine
University of Nebraska Medical Center
Omaha, NE




Steven D. Gore, MD
Professor of Hematology/Oncology
Sidney Kimmel Comprehensive Cancer Center
Johns Hopkins University
Baltimore, MD



 


Thomas E. Witzig, MD
Professor of Medicine
Division of Hematology
Department of Internal Medicine
Mayo Clinic
College of Medicine
Rochester, MN




André Goy, MD, MS
Chief, Lymphoma Division
The Cancer Center Hackensack University Medical Center
Hackensack, NJ



 


Anas Younes, MD
Director, Clinical and Translational Research Program
Department of Lymphoma/Myeloma
Division of Cancer Medicine
The University of Texas M.D. Anderson Cancer Center
Houston, TX




Richard A. Larson, MD
Professor of Medicine
Director of Hematologic Malignancies Clinical Research Program
The University of Chicago Medical Center
Chicago, IL

 


Andrew D. Zelenetz, MD, PhD
Chief, Lymphoma Service
Memorial Sloan-Kettering Cancer Center
New York, NY




Nikhil C. Munshi, MD
Associate Professor of Medicine
Harvard Medical School
Jerome Lipper Multiple Myeloma Center
Dana-Farber Cancer Institute
Boston, MA

 


Jane N. Winter, MD
Professor of Medicine
Division of Hematology/Oncology
Northwestern University Feinberg School of Medicine
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Chicago, IL



Educational Grants
Pending
© 2010 Oncology Learning Center
1415 Legacy Drive, Suite 250 • Frisco, TX 75034 • Registration Phone: 214.269.2014 • Fax: 214.866.0311
Contact Us
Disclaimer: The material published on the Oncology Learning Center Web site reflect the opinions and expertise of the authors and/or reviewers of the material, and not the opinions of the Oncology Learning Center, the CME provider, or the pharmaceutical companies providing educational grants. The materials may address uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. Before using any therapeutic approaches reviewed in this material, a qualified medical or surgical oncologist, or hematologist should be consulted. Readers of this content should verify all information and data before treating patients or using any drugs or therapies described in any Oncology Learning Center materials. Click here for our Privacy Policy.